Biocartis Group NV
Biocartis Group NV (BCART.BR) Stock Competitors & Peer Comparison
See (BCART.BR) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BCART.BR | €0.29 | +0.00% | 27.2M | -0.32 | -€0.92 | N/A |
| ERF.PA | €61.48 | -0.52% | 11B | 24.35 | €2.55 | +0.97% |
| BIM.PA | €89.95 | +0.33% | 10.5B | 26.77 | €3.34 | +1.01% |
| LBIRD.PA | €20.00 | -2.91% | 442.6M | 41.88 | €0.48 | N/A |
| MDXH.BR | €3.02 | -3.76% | 85.6M | -1.58 | -€1.91 | N/A |
| ALECR.PA | €16,100.00 | +0.00% | 81.2M | 13.17 | €1,222.20 | N/A |
| ALBIO.PA | €0.80 | -4.76% | 14.7M | -0.20 | -€3.98 | N/A |
| ALPRE.PA | €3.09 | +0.00% | 12.1M | -2.92 | -€1.06 | N/A |
| EEP.MC | €0.54 | N/A | 6.2M | -54.00 | -€0.01 | N/A |
| MLAHC.PA | €0.60 | +0.00% | 5.4M | -10.00 | -€0.06 | N/A |
Stock Comparison
BCART.BR vs ERF.PA Comparison April 2026
BCART.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCART.BR stands at 27.2M. In comparison, ERF.PA has a market cap of 11B. Regarding current trading prices, BCART.BR is priced at €0.29, while ERF.PA trades at €61.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCART.BR currently has a P/E ratio of -0.32, whereas ERF.PA's P/E ratio is 24.35. In terms of profitability, BCART.BR's ROE is +2.04%, compared to ERF.PA's ROE of +0.12%. Regarding short-term risk, BCART.BR is more volatile compared to ERF.PA. This indicates potentially higher risk in terms of short-term price fluctuations for BCART.BR.Check ERF.PA's competition here